| http://www.w3.org/ns/prov#value | - Although combined estrogen and progestin therapy decreases the risk of fractures in postmenopausal women (about 46 fractures of any type prevented per 10,000 person-years), there is an accompanying increased risk of serious adverse events, such as stroke, invasive breast cancer, dementia, gallbladder disease, DVT, and pulmonary embolism (Table 2).
|
